| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/08/2010 | US20100173844 Stable Formulations of Peptides |
| 07/08/2010 | US20100173843 Tissue adhering compositions |
| 07/08/2010 | US20100173842 Vaccine for staphylococcal infections |
| 07/08/2010 | US20100173841 Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen |
| 07/08/2010 | US20100173840 Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof |
| 07/08/2010 | US20100173839 Stabilized insulin-like growth factor polypeptides |
| 07/08/2010 | US20100173838 Novel process for the preparation of cyclosporin derivatives |
| 07/08/2010 | US20100173837 Dosing forms and regimens comprising 3-[(r)-2-(n,n-dimethylamino)ethylthio-sar]-4-(gammahydroxymethylleucine)cyclosporine |
| 07/08/2010 | US20100173836 Novel macrocycles |
| 07/08/2010 | US20100173835 Peptides for Treatment of Obesity |
| 07/08/2010 | US20100173834 Cyclic peptide melanocortin receptor ligands |
| 07/08/2010 | US20100173833 Methods and composition for use of cyclic analogues of histatin |
| 07/08/2010 | US20100173832 Anticancerous polymeric agents |
| 07/08/2010 | US20100173831 Factor viii polymer conjugates |
| 07/08/2010 | US20100173830 Factor viii polymer conjugates |
| 07/08/2010 | US20100173829 Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof |
| 07/08/2010 | US20100173828 Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof |
| 07/08/2010 | US20100173827 Role of proline rich peptides in cellular communication mechanisms and treatment of diseases |
| 07/08/2010 | US20100173826 Smooth Muscle Relaxation |
| 07/08/2010 | US20100173825 Heteroaryl benzamide derivatives |
| 07/08/2010 | US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents |
| 07/08/2010 | US20100173823 Alpha2c adrenoreceptor agonists |
| 07/08/2010 | US20100173822 Composition comprising saccarides & peptides & uses thereof |
| 07/08/2010 | US20100173412 Eukaryotic Layered Vector Initiation Systems |
| 07/08/2010 | US20100173383 Nuclear Factor Of Activated T Cells Receptor |
| 07/08/2010 | US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/08/2010 | US20100173314 Diagnostic methods using tenascin-w compositions |
| 07/08/2010 | US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/08/2010 | US20100173005 Microparticle formulations for sustained-release of bioactive compounds |
| 07/08/2010 | US20100173001 Metal Ion-Treated Biocompatible Polymers Useful for Nanoparticles |
| 07/08/2010 | US20100172999 Polynuclear Microcapsules |
| 07/08/2010 | US20100172998 Process for preparing microparticles through phase inversion phenomena |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172976 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 07/08/2010 | US20100172966 Methods and compositions for cellular reprogramming |
| 07/08/2010 | US20100172964 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 07/08/2010 | US20100172962 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 07/08/2010 | US20100172961 Encapsulated Peptide Amphiphile Nanostructures |
| 07/08/2010 | US20100172959 Reservoir system with closed membrane |
| 07/08/2010 | US20100172953 Biopolymer Based Implantable Degradable Devices |
| 07/08/2010 | US20100172950 Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 kda and processes for their preparation |
| 07/08/2010 | US20100172949 Consensus peptide |
| 07/08/2010 | US20100172943 Peptide nanoparticles and uses therefor |
| 07/08/2010 | US20100172942 Multi-membrane immunoisolation system for cellular transplant |
| 07/08/2010 | US20100172938 Modified bacterial surface layer proteins |
| 07/08/2010 | US20100172932 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172925 Hla-a2-restricted t-cell epitopes of the respiratory syncytial virus fusion protein as peptide-based vaccines |
| 07/08/2010 | US20100172922 Expression and Purification of HIP/PAP and Uses Therefor |
| 07/08/2010 | US20100172919 Noveltreatment for neurological disorders |
| 07/08/2010 | US20100172916 Substituted hydroxyphenylamine compounds |
| 07/08/2010 | US20100172915 Compositions and methods of using angiopoietin-like 4 protein |
| 07/08/2010 | US20100172914 Methods and materials related to trail isoforms |
| 07/08/2010 | US20100172908 Methods and compositions for treating diseases targeting maba1 |
| 07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
| 07/08/2010 | US20100172898 Microstructure synthesis by flow lithography and polymerization |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/08/2010 | US20100172892 Hyaluronidase and method of use thereof |
| 07/08/2010 | US20100172891 Recombinant human blood coagulation factor VIII protein, composition, use of a recombinant factor VIII protein, use of a composition, method of obtaining a recombinant human blood coagulation factor VIII protein and use thereof |
| 07/08/2010 | US20100172890 Agmatine containing dietary supplements, nutraceuticals, and foods |
| 07/08/2010 | US20100172889 Degradable biomolecule compositions |
| 07/08/2010 | US20100172886 Method for Promoting Wound Healing |
| 07/08/2010 | US20100172882 Compositions and methods for targeted inactivation of hiv cell surface receptors |
| 07/08/2010 | US20100172881 Use of tailored recombinases for the treatment of retroviral infections |
| 07/08/2010 | US20100172879 Amyloid beta peptides and methods of use |
| 07/08/2010 | US20100172878 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes |
| 07/08/2010 | US20100172875 Oil-in-water emulsion and its use for the delayed release of active elements |
| 07/08/2010 | US20100172870 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 07/08/2010 | US20100172869 Method for treating multiple sclerosis |
| 07/08/2010 | US20100172868 Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| 07/08/2010 | US20100172867 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds |
| 07/08/2010 | US20100172866 Combination Therapy for the Treatment of HCV Infection |
| 07/08/2010 | US20100172865 Methods of enhancing hair growth |
| 07/08/2010 | US20100172864 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 07/08/2010 | US20100172863 Enhanced medical implant |
| 07/08/2010 | US20100172862 Stable antibody compositions and methods of stabilizing same |
| 07/08/2010 | US20100172861 Anionic Polymers as Toxin Binders and Antibacterial Agents |
| 07/08/2010 | US20100172851 Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites |
| 07/08/2010 | US20100172849 Silicone elastomer gels |
| 07/08/2010 | US20100172844 Albumin binding molecules and uses thereof |
| 07/08/2010 | US20100172837 MN Gene and Protein |
| 07/08/2010 | US20100172835 Methods and compositions for synaphically-targeted treatment for cancer |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | DE10351661B4 Verfahren zur Herstellung eines Kompositmaterials, dadurch hergestelltes Kompositmaterial und dessen Verwendung A process for producing a composite material, composite material produced thereby and the use thereof |
| 07/08/2010 | DE102004012273B4 Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern Stable and taste masked pharmaceutical dosage form using porous apatite grains |
| 07/08/2010 | CA2749757A1 Injectable botulinum toxin formulations |
| 07/08/2010 | CA2748811A1 Stroke-generated angiogenesis enhancers and uses thereof |
| 07/08/2010 | CA2748716A1 Dominant negative wnt2 compositions and methods of use |
| 07/08/2010 | CA2748517A1 Prophylactic/therapeutic agent for cancer |
| 07/08/2010 | CA2748493A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 07/08/2010 | CA2748389A1 Derivatives of cyclosporin a |
| 07/08/2010 | CA2748340A1 .beta.-arrestin effectors and compositions and methods of use thereof |
| 07/08/2010 | CA2748233A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor |
| 07/08/2010 | CA2747790A1 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants |
| 07/08/2010 | CA2747404A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/08/2010 | CA2746506A1 Method of modulating hsf-1 |
| 07/07/2010 | EP2204381A1 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 07/07/2010 | EP2204379A1 Polypeptide compound |
| 07/07/2010 | EP2204378A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agent, a method for modifying the agent and its use for manufacturing a medicament for treating tumor |
| 07/07/2010 | EP2204193A2 Novel spacer moiety for poly(ethylene glycol)-modified peptide-based compounds |